Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 22, 2021 - Issue 3
Submit an article Journal homepage
5,677
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Real-World Evidence for Long-Term Safety and Effectiveness of Ipragliflozin in Japanese Patients with Type 2 Diabetes Mellitus: final Results of a 3-Year Post-Marketing Surveillance Study (STELLA-LONG TERM)

Ichiro Nakamuraa Operational Excellence, Medical Affairs Japan, Astellas Pharma Inc., Tokyo, JapanCorrespondence[email protected]
View further author information
,
Hiroshi Maegawab Department of Medicine, Shiga University of Medical Science, Shiga, JapanView further author information
,
Kazuyuki Tobec First Department of Internal Medicine, Graduate School of Medicine and Pharmaceutical Sciences for Research, University of Toyama, Toyama, JapanView further author information
&
Satoshi Unod Data Science, Development, Astellas Pharma Inc., Tokyo, JapanView further author information
Pages 373-387 | Received 21 Jul 2020, Accepted 27 Aug 2020, Published online: 03 Oct 2020

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.